Perspective Therapeutics (CATX) Revenue (2010 - 2023)
Perspective Therapeutics' (CATX) quarterly Revenue came in at -$4.9 million in Q4 2023, down 324.35% quarter-over-quarter from $2.2 million in Q3 2023.
Analysis
Perspective Therapeutics (CATX) Revenue (2010 - 2023) Analysis & Trends
Perspective Therapeutics has disclosed Revenue across 14 years of filings, most recently posting -$4.9 million for Q4 2023.
- In Q4 2023, Revenue changed N/A year-over-year to -$4.9 million; the TTM figure through Dec 2023 stood at $1.4 million (changed N/A YoY), while the FY2023 annual figure was $1.4 million, changed N/A from the prior year.
- Revenue came in at -$4.9 million for Q4 2023 at Perspective Therapeutics, down from $2.2 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $7.1 million in Q3 2022 to a low of -$4.9 million in Q4 2023.
- Average Revenue over 5 years is $2.4 million, with a median of $2.4 million recorded in 2020.
- Year-over-year, Revenue soared 178.16% in 2022 and tumbled 69.36% in 2023.
- Over 5 years, Revenue stood at $2.2 million in 2019, then advanced by 6.94% to $2.4 million in 2020, then increased by 19.37% to $2.8 million in 2021, then soared by 153.27% to $7.1 million in 2022, then tumbled by 168.73% to -$4.9 million in 2023.
- Per Business Quant data, the three most recent Revenue figures were -$4.9 million in Q4 2023, $2.2 million in Q3 2023, and $2.1 million in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 10.05 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 7.80 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 3.33 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 4.29 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 145.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 2.74 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Perspective Therapeutics | 358.23 Mn | 358.23 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -4.90 Mn |
| Sep 30, 2023 | 2.19 Mn |
| Jun 30, 2023 | 2.09 Mn |
| Mar 31, 2023 | 2.06 Mn |
| Sep 30, 2022 | 7.13 Mn |
| Jun 30, 2022 | 5.42 Mn |
| Mar 31, 2022 | 2.91 Mn |
| Dec 31, 2021 | 2.82 Mn |
| Sep 30, 2021 | 2.56 Mn |
| Jun 30, 2021 | 2.71 Mn |
| Mar 31, 2021 | 2.60 Mn |
| Dec 31, 2020 | 2.36 Mn |
| Sep 30, 2020 | 2.38 Mn |
| Jun 30, 2020 | 2.28 Mn |
| Mar 31, 2020 | 2.88 Mn |
| Dec 31, 2019 | 2.21 Mn |
| Sep 30, 2019 | 2.32 Mn |
| Jun 30, 2019 | 1.92 Mn |
| Mar 31, 2019 | 1.92 Mn |
| Dec 31, 2018 | 1.90 Mn |